TLR9 and endothelial dysfunction: These effects were reversed by blocking the TLR9, thus demonstrating the involvement of the mt-cfDNA and the innate immune system pattern recognition receptor TLR9 in the pathogenesis of hypertension and endothelial dysfunction.